PER percheron therapeutics limited

EQUITY RESEARCH REPORT - WILSON dated 18 Jan 2022, page-114

  1. 90 Posts.
    lightbulb Created with Sketch. 38
    I agree with you about the lack of mgmt transparency in their communication to SHs especially after CR.

    However, could you please elaborate on why you believe the design and the options were a sort of compromise?

    IMO they should have given options to the current holders and invite instos to join CR like any other company would have done, instead they let the instos manipulate the price down and buy before the recorded date so that they could double their fill on oppies.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
-0.001(5.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $1.424K 153.5K

Buyers (Bids)

No. Vol. Price($)
7 1819680 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 1733198 6
View Market Depth
Last trade - 14.56pm 01/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.